A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2018
At a glance
- Drugs Letrozole (Primary)
- Indications Leiomyosarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Jul 2017 Status changed from active, no longer recruiting to discontinued due to low accrual.
- 04 Nov 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.